Interview with Alina Culcea, Managing Director, Actavis Romania
We understand that you already took over the reins at Actavis as interim GM in late 2009, before being officially appointed a few months later in 2010. What have been…
Address: Actavis Romania, Ion Mihalache Blvd. 11, sector 1, Bucharest 011 171, Romania
Tel: +40 21 351 45 67
Web: http://www.actavis.com.ro/ro/default.htm
Having joined Actavis Group in March 2006, the Romanian division strengthens the group’s oncology actavities. The Romanian branch embraces the Group’s center of excellence for the development, production and marketing of generic oncology medicines.
With a broad portfolio of oncology products, the company has a successful presence in a growing number of foreign markets. The latest market within the portfolio are in the United States and Japan, where since 2008, the company sells oncology products manufactured in the production unit in Bucharest – Sindan Pharma, a company previously acquired by Actavis Group in 2006.
Actavis offers its customers the broadest product portfolio and the most advanced production line of generic drugs. Currently, Actavis sells over 830 products (over 10,000 SKUs) in hospitals and pharmacies around the world, covering all relevant therapeutic areas. In 2008, the Company has launched over 660 products (235 molecules) and for 2009 it is expected that number to rise to 800 launches of new products.
We understand that you already took over the reins at Actavis as interim GM in late 2009, before being officially appointed a few months later in 2010. What have been…
PharmaBoardroom takes a look at the careers of five pharma executives who we spoke to as Romania country managers back in 2015. At the end of 2019, all of them…
Here we highlight five of the most important women working in healthcare and the life sciences in Central & Eastern Europe (CEE) today. From regulators to pharma affiliate heads with…
Multinationals have struggled to adapt their Romanian strategies, but the local production sector appears to be flourishing. Much of this impetus relates directly to EU accession and the harmonization of…
No one can accuse the Romanian government of being lethargic when it comes to healthcare reform. After an unprecedented seven years of zero new molecules being admitted to the state…
Once touted by the IMS as one of the “fast followers” among the world’s “pharmerging” nations and feted by the international investor community in the wake of EU accession, Romania’s…
Raed Arafat, Secretary of State at the Romanian Ministry of Internal Affairs highlights the key trends in Romanian healthcare over recent years, his own role in reforming the country’s healthcare…
The managing partner of a specialist boutique PR and integrated communications management agency serving the local pharma sector unveils his theory of holistic, industry-wide lobbying and gives some pointers as…
The general manager of a British pharma giant with over 25 years of presence in Romania discusses how vaccination programs can play a significant role in increasing the cost-effectiveness of the…
The directors of one of the leading in country contract research organisations, explain exactly what makes Romania such an attractive destination for clinical trials. They also give some indications of…
The directors of one of the leading in country contract research organisations, explain exactly what makes Romania such an attractive destination for clinical trials. They also give some indications of…
The general manager of one of the leading CROs in Romania explains how the country in gathering pace as a top tier clinical trials destination country within the region and…
The country manager of one of the foremost providers of sustainable and integrated healthcare solutions describes the sorts of local adaptations that need to be enacted when launching a product on the…
See our Cookie Privacy Policy Here
